Minimally Invasive Sensing of Beta-lactam Antibiotics

• Status: Completed
• Trial end date: 2018-08-10
• Target enrollment: 0
• Participant gender: All

Summary

This study is an in-house feasibility study of a microneedle biosensor developed within Imperial College London.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Imperial College London
• Treatments: Anti-Bacterial Agents; beta-Lactams; Lactams; Penicillin V; Penicillins

Criteria

Inclusion Criteria:

• Adult >18 years old

• Healthy with no evidence of active infection

• Previously received penicillin with no adverse effects

Exclusion Criteria:

• High risk of skin soft tissue infection or local skin and soft tissue infection near sensor site

• Previous history of allergies to adhesive strips or active dermatitis

• Penicillin allergy or previous adverse event whilst receiving penicillin

• Anaemia on screening bloods (defined as haemoglobin <13 g/dL in males and <12 g/dL in females)